Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
1
17%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(3)
Terminated(1)
Other(2)

Detailed Status

Completed3
unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
75.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

unknown233%
completed350%
terminated117%

Recent Activity

0 active trials
Showing 5 of 6
completed

Repeated Employee Testing for Understanding Our Recovery to Normal

NCT04472793
unknownnot_applicable

Virus and Bronchial Epithelium in Children and the Elderly

NCT06224062
unknown

A Cohort Study on the Clinical Characteristics and Prognosis of HIV/AIDS Patients Infected With SARS-CoV-2

NCT06172816
completed

Home Usability Study of the SARS-CoV-2 (COVID-19) Test

NCT04395391
completed

A Prospective Virtual Study to Evaluate the Longevity of IgG Antibodies in Individuals Exposed to COVID-19

NCT05042193
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04472793

Repeated Employee Testing for Understanding Our Recovery to Normal

Completed
NCT06224062Not Applicable

Virus and Bronchial Epithelium in Children and the Elderly

Unknown
NCT06172816

A Cohort Study on the Clinical Characteristics and Prognosis of HIV/AIDS Patients Infected With SARS-CoV-2

Unknown
NCT04395391

Home Usability Study of the SARS-CoV-2 (COVID-19) Test

Completed
NCT05042193

A Prospective Virtual Study to Evaluate the Longevity of IgG Antibodies in Individuals Exposed to COVID-19

Completed
NCT04566965

Serology to COVID-19 for Recording Exposures and Evaluating Needs

Terminated

All 6 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
6